Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Third Party Perspective
1.3.5. Primary research
1.3.6. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Data Sources
1.8. List of Primary Sources
1.9. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. and Europe Clinical Wearable Medical Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of chronic diseases
3.2.1.2. Increasing geriatric population
3.2.1.3. Advent of technologically advanced products
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of devices and lack of reimbursement policies
3.2.2.2. Product recalls
3.2.3. Market Opportunities Analysis
3.2.3.1. Growing clinical trials
3.2.3.2. Increasing demand for remote monitoring
3.2.3.3. Rising focus on wearable artificial kidney devices
3.2.4. Market Challenge Analysis
3.2.4.1. Accuracy and reliability
3.3. U.S. and Europe Clinical Wearable Medical Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. U.S. and Europe Clinical Wearable Medical Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. and Europe Clinical Wearable Medical Devices Market Movement Analysis
4.3. U.S. and Europe Clinical Wearable Medical Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Insulin Pumps and Continuous Glucose Monitors (CGMs)
4.4.1. Insulin Pumps and Continuous Glucose Monitors (CGMs) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.2. Connected Insulin Pumps
4.4.2.1. Connected Insulin Pumps Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4.3. Continuous Glucose Monitoring Devices
4.4.3.1. Continuous Glucose Monitoring Devices Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Cardiac Monitors
4.5.1. Cardiac Monitors Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.2. Portable ECG Monitors
4.5.2.1. Portable ECG Monitors Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5.3. Cardiac Event Monitors
4.5.3.1. Cardiac Event Monitors Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6. Respiratory Monitoring Devices
4.6.1. Respiratory Monitoring Devices Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6.2. Wearable Spirometers
4.6.2.1. Wearable Spirometers Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.6.3. Connected Inhalers
4.6.3.1. Connected Inhalers Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.7. Neurostimulators
4.7.1. Neurostimulators Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.7.2. Wearable Vagus Nerve Stimulators (VNS)
4.7.2.1. Wearable Vagus Nerve Stimulators (VNS) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.7.3. Wearable Deep Brain Stimulators (DBS)
4.7.3.1. Wearable Deep Brain Stimulators (DBS) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.8. Blood Pressure Monitors
4.8.1. Blood Pressure Monitors Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.8.2. Ambulatory Blood Pressure Monitors
4.8.2.1. Ambulatory Blood Pressure Monitors Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.8.3. Smart Blood Pressure Cuffs
4.8.3.1. Smart Blood Pressure Cuffs Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.9. Wearable Dialysis Devices
4.9.1. Wearable Dialysis Devices Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.10. Wearable Oxygen Therapy Devices
4.10.1. Wearable Oxygen Therapy Devices Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.11. Other Wearable Medical Devices
4.11.1. Other Wearable Medical Devices Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. U.S. and Europe Clinical Wearable Medical Devices Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. and Europe Clinical Wearable Medical Devices Market Movement Analysis
5.3. U.S. and Europe Clinical Wearable Medical Devices Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Chronic Disease Management
5.4.1. Chronic Disease Management Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.2. Diabetes
5.4.2.1. Diabetes Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.3. Cardiovascular Disorders
5.4.3.1. Cardiovascular Disorders Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.4. Respiratory Disorders
5.4.4.1. Respiratory Disorders Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.5. Neurological Disorders
5.4.5.1. Neurological Disorders Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4.6. Other Chronic Conditions
5.4.6.1. Other Chronic Conditions Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Post-operative Care
5.5.1. Post-operative Care Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Remote Patient Monitoring (RPM)
5.6.1. Remote Patient Monitoring (RPM) Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Other Applications
5.7.1. Other Applications Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. U.S. and Europe Clinical Wearable Medical Devices Market: Connectivity Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. and Europe Clinical Wearable Medical Devices Market Movement Analysis
6.3. U.S. and Europe Clinical Wearable Medical Devices Market Size & Trend Analysis, by Connectivity Type, 2018 to 2030 (USD Million)
6.4. Bluetooth Connected
6.4.1. Bluetooth Connected Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Wi-Fi-enabled
6.5.1. Wi-Fi-enabled Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Cellular-connected
6.6.1. Cellular-connected Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.7. IoT-based
6.7.1. IoT-based Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. U.S. and Europe Clinical Wearable Medical Devices Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. and Europe Clinical Wearable Medical Devices Market Movement Analysis
7.3. U.S. and Europe Clinical Wearable Medical Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Home Healthcare
7.4.1. Home Healthcare Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Hospitals and Clinics
7.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Ambulatory Care Settings
7.6.1. Ambulatory Care Settings Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.7. Other Settings
7.7.1. Other Settings Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Medtronic
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Product Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. Abbott
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Product Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. Koninklijke Philips N.V.
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Product Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. GE HealthCare
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Product Benchmarking
8.2.4.4. Strategic Initiatives
8.2.5. OMRON Healthcare, Inc.
8.2.5.1. Company Overview
8.2.5.2. Financial Performance
8.2.5.3. Product Benchmarking
8.2.5.4. Strategic Initiatives
8.2.6. Dexcom, Inc.
8.2.6.1. Company Overview
8.2.6.2. Financial Performance
8.2.6.3. Product Benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. Insulet Corporation
8.2.7.1. Company Overview
8.2.7.2. Financial Performance
8.2.7.3. Product Benchmarking
8.2.7.4. Strategic Initiatives
8.2.8. Tandem Diabetes Care, Inc.
8.2.8.1. Company Overview
8.2.8.2. Financial Performance
8.2.8.3. Product Benchmarking
8.2.8.4. Strategic Initiatives
8.2.9. Fresenius Medical Care AG
8.2.9.1. Company Overview
8.2.9.2. Financial Performance
8.2.9.3. Product Benchmarking
8.2.9.4. Strategic Initiatives
8.2.10. Inogen
8.2.10.1. Company Overview
8.2.10.2. Financial Performance
8.2.10.3. Product Benchmarking
8.2.10.4. Strategic Initiatives
8.2.11. Cognita Labs
8.2.11.1. Company Overview
8.2.11.2. Financial Performance
8.2.11.3. Product Benchmarking
8.2.11.4. Strategic Initiatives
8.2.12. AliveCor, Inc.
8.2.12.1. Company Overview
8.2.12.2. Financial Performance
8.2.12.3. Product Benchmarking
8.2.12.4. Strategic Initiatives
8.2.13. EMAY
8.2.13.1. Company Overview
8.2.13.2. Financial Performance
8.2.13.3. Product Benchmarking
8.2.13.4. Strategic Initiatives
8.2.14. VivaLNK, Inc.
8.2.14.1. Company Overview
8.2.14.2. Financial Performance
8.2.14.3. Product Benchmarking
8.2.14.4. Strategic Initiatives
8.2.15. CAIRE Inc
8.2.15.1. Company Overview
8.2.15.2. Financial Performance
8.2.15.3. Product Benchmarking
8.2.15.4. Strategic Initiatives
8.2.16. Ypsomed AG
8.2.16.1. Company Overview
8.2.16.2. Financial Performance
8.2.16.3. Product Benchmarking
8.2.16.4. Strategic Initiatives
8.2.17. Wellue
8.2.17.1. Company Overview
8.2.17.2. Financial Performance
8.2.17.3. Product Benchmarking
8.2.17.4. Strategic Initiatives
8.2.18. Qardio, Inc
8.2.18.1. Company Overview
8.2.18.2. Financial Performance
8.2.18.3. Product Benchmarking
8.2.18.4. Strategic Initiatives
8.2.19. Withings
8.2.19.1. Company Overview
8.2.19.2. Financial Performance
8.2.19.3. Product Benchmarking
8.2.19.4. Strategic Initiatives
8.2.20. iRhythm Technologies, Inc
8.2.20.1. Company Overview
8.2.20.2. Financial Performance
8.2.20.3. Product Benchmarking
8.2.20.4. Strategic Initiatives
8.2.21. OxyGo HQ Florida, LLC.
8.2.21.1. Company Overview
8.2.21.2. Financial Performance
8.2.21.3. Product Benchmarking
8.2.21.4. Strategic Initiatives
8.2.22. LOOKEETech
8.2.22.1. Company Overview
8.2.22.2. Financial Performance
8.2.22.3. Product Benchmarking
8.2.22.4. Strategic Initiatives
8.2.23. VitalConnect
8.2.23.1. Company Overview
8.2.23.2. Financial Performance
8.2.23.3. Product Benchmarking
8.2.23.4. Strategic Initiatives
8.2.24. Boston Scientific Corporation
8.2.24.1. Company Overview
8.2.24.2. Financial Performance
8.2.24.3. Product Benchmarking
8.2.24.4. Strategic Initiatives
8.2.25. Nexstim
8.2.25.1. Company Overview
8.2.25.2. Financial Performance
8.2.25.3. Product Benchmarking
8.2.25.4. Strategic Initiatives
8.2.26. LivaNova PLC
8.2.26.1. Company Overview
8.2.26.2. Financial Performance
8.2.26.3. Product Benchmarking
8.2.26.4. Strategic Initiatives
8.2.27. Neuropace Inc.
8.2.27.1. Company Overview
8.2.27.2. Financial Performance
8.2.27.3. Product Benchmarking
8.2.27.4. Strategic Initiatives
8.2.28. Nevro Corporation
8.2.28.1. Company Overview
8.2.28.2. Financial Performance
8.2.28.3. Product Benchmarking
8.2.28.4. Strategic Initiatives
8.2.29. electroCore, Inc.
8.2.29.1. Company Overview
8.2.29.2. Financial Performance
8.2.29.3. Product Benchmarking
8.2.29.4. Strategic Initiatives
8.2.30. tVNS Technologies GmbH
8.2.30.1. Company Overview
8.2.30.2. Financial Performance
8.2.30.3. Product Benchmarking
8.2.30.4. Strategic Initiatives
8.2.31. Laborie
8.2.31.1. Company Overview
8.2.31.2. Financial Performance
8.2.31.3. Product Benchmarking
8.2.31.4. Strategic Initiatives
8.2.32. Axonics, Inc
8.2.32.1. Company Overview
8.2.32.2. Financial Performance
8.2.32.3. Product Benchmarking
8.2.32.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. U.S. and Europe Clinical Wearable Medical Devices Market, by Product, 2018-2030 (USD Million)
Table 4. U.S. and Europe Clinical Wearable Medical Devices Market, by Application, 2018-2030 (USD Million)
Table 5. U.S. and Europe Clinical Wearable Medical Devices Market, by Connectivity Type, 2018-2030 (USD Million)
Table 6. U.S. and Europe Clinical Wearable Medical Devices Market, by End Use, 2018-2030 (USD Million)
Table 7. Participant’s Overview
Table 8. Financial Performance
Table 9. Product Benchmarking
Table 10. Strategic Initiatives
List of Figures
Figure 1 U.S. and Europe clinical wearable medical devices market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Value chain-based size & forecasting
Figure 6 Market formulation & validation
Figure 7 Market snapshot (U.S. and Europe)
Figure 8 Product type and application segment snapshot
Figure 9 Connectivity type and end use segment snapshot
Figure 10 Competitive landscape snapshot
Figure 11 Global neuromodulation market and U.S. and Europe clinical wearable medical devices market value, 2024 (USD Billion)
Figure 12 Market dynamics
Figure 13 Number of Americans aged 65 or over from 2022 to 2050 (in Millions)
Figure 14 Older population projection, UK from 2022 to 2072 (in Millions)
Figure 15 Porter’s five forces analysis
Figure 16 PESTLE analysis
Figure 17 U.S. and Europe clinical wearable medical devices market: Product outlook and key takeaways
Figure 18 U.S. and Europe clinical wearable medical devices market: Product movement analysis
Figure 19 Insulin pumps and Continuous Glucose Monitors (CGMs) market estimates and forecast, 2018-2030 (USD Million)
Figure 20 Connected insulin pumps market estimates and forecast, 2018-2030 USD Million
Figure 21 Continuous glucose monitoring devices market estimates and forecast, 2018-2030 (USD Million)
Figure 22 Cardiac monitors market estimates and forecast, 2018-2030 (USD Million)
Figure 23 Portable ECG monitors market estimates and forecast, 2018-2030 (USD Million)
Figure 24 Cardiac event monitors market estimates and forecast, 2018-2030 (USD Million)
Figure 25 Respiratory monitoring devices market estimates and forecast, 2018-2030 (USD Million)
Figure 26 Wearable spirometers market estimates and forecast, 2018-2030 (USD Million)
Figure 27 Connected inhalers market estimates and forecast, 2018-2030 (USD Million)
Figure 28 Neurostimulators market estimates and forecast, 2018-2030 (USD Million)
Figure 29 Wearable vagus nerve stimulators (VNS) market estimates and forecast, 2018-2030 (USD Million)
Figure 30 Wearable deep brain stimulators (DBS) market estimates and forecast, 2018-2030 USD Million
Figure 31 Blood pressure monitors market estimates and forecast, 2018-2030 (USD Million)
Figure 32 Ambulatory blood pressure monitors market estimates and forecast, 2018-2030 (USD Million)
Figure 33 Smart blood pressure cuffs market estimates and forecast, 2018-2030 (USD Million)
Figure 34 Wearable dialysis devices (portable dialysis machines) market estimates and forecast, 2018-2030 (USD Million)
Figure 35 Wearable oxygen therapy devices (portable oxygen concentrators market estimates and forecast, 2018-2030 (USD Million)
Figure 36 Other clinical wearable medical devices market estimates and forecast, 2018-2030 (USD Million)
Figure 37 U.S. and Europe clinical wearable medical devices market: Application outlook and key takeaways
Figure 38 U.S. and Europe clinical wearable medical devices market: Application movement analysis
Figure 39 Chronic disease management market estimates and forecast, 2018-2030 (USD Million)
Figure 40 Diabetes market estimates and forecast, 2018-2030 (USD Million)
Figure 41 Cardiovascular disorders market estimates and forecast, 2018-2030 (USD Million)
Figure 42 Respiratory disorders market estimates and forecast, 2018-2030 (USD Million)
Figure 43 Neurological disorders market estimates and forecast, 2018-2030 (USD Million)
Figure 44 Other chronic conditions market estimates and forecast, 2018-2030 (USD Million)
Figure 45 Post-operative market estimates and forecast, 2018-2030 (USD Million)
Figure 46 Remote patient monitoring market estimates and forecast, 2018-2030 (USD Million)
Figure 47 Other applications market estimates and forecast, 2018-2030 (USD Million)
Figure 48 U.S. and Europe clinical wearable medical devices market: Connectivity type outlook and key takeaways
Figure 49 U.S. and Europe clinical wearable medical devices market: Connectivity type movement analysis
Figure 50 Bluetooth connected market estimates and forecast, 2018-2030 (USD Million)
Figure 51 WI-FI-enabled market estimates and forecast, 2018-2030 (USD Million
Figure 52 Cellular-connected market estimates and forecast, 2018-2030 (USD Million)
Figure 53 IoT-based market estimates and forecast, 2018-2030 (USD Million)
Figure 54 U.S. and Europe clinical wearable medical devices market: End use outlook and key takeaways
Figure 55 U.S. and Europe clinical wearable medical devices market: End use movement analysis0
Figure 56 Home healthcare market estimates and forecast, 2018-2030 (USD Million)
Figure 57 Hospitals and clinics market estimates and forecast, 2018-2030 (USD Million)
Figure 58 Ambulatory care settings market estimates and forecast, 2018-2030 (USD Million)
Figure 59 Other settings (long term care settings, etc.) market estimates and forecast, 2018-2030 (USD Million)
Figure 60 U.S. and Europe clinical wearable medical devices market revenue by region, 2024 & 2030 (USD Million)
Figure 61 Regional marketplace: Key takeaways
Figure 62 Key country dynamics
Figure 63 U.S. clinical wearable medical devices market, 2018-2030 (USD Million)
Figure 64 Europe clinical wearable medical devices market, 2018-2030 (USD Million)
Figure 65 Key country dynamics
Figure 66 UK clinical wearable medical devices market, 2018-2030 (USD Million)
Figure 67 Key country dynamics
Figure 68 Germany clinical wearable medical devices market, 2018-2030 (USD Million)
Figure 69 Key country dynamics
Figure 70 France clinical wearable medical devices market, 2018-2030 (USD Million)
Figure 71 Key country dynamics
Figure 72 Italy clinical wearable medical devices market, 2018-2030 (USD Million)
Figure 73 Key country dynamics
Figure 74 Spain clinical wearable medical devices market, 2018-2030 (USD Million)
Figure 75 Key country dynamics
Figure 76 Sweden clinical wearable medical devices market, 2018-2030 (USD Million)
Figure 77 Key country dynamics
Figure 78 Denmark clinical wearable medical devices market, 2018-2030 (USD Million)
Figure 79 Key country dynamics
Figure 80 Norway clinical wearable medical devices market, 2018-2030 (USD Million)
Figure 81 Key company categorization
Figure 82 U.S. and Europe clinical wearable medical devices market share analysis, 2024, neurostimulators
Figure 83 U.S. and Europe clinical wearable medical devices market share analysis, 2024, Continuous Glucose Monitors (CGMs)
Figure 84 U.S. and Europe clinical wearable medical devices market share analysis, 2024, connected insulin pumps
Figure 85 U.S. and Europe clinical wearable medical devices market share analysis, 2024, blood pressure monitors
Figure 86 U.S. and Europe clinical wearable medical devices market share analysis, 2024, oxygen concentrators
Figure 87 U.S. and Europe clinical wearable medical devices market share analysis, 2024, wearable dialysis devices (portable dialysis machines)
Figure 88 Strategic framework
